Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver

FEBS Letters

Volumn 581, Issue 26, 2007, Pages 5029-5033

  Oku, Hiroyuki ^a   Matsuura, Fumihiko ^a   Koseki, Masahiro ^a   Sandoval, Jose C ^a   Yuasa Kawase, Miyako ^a   Tsubakio Yamamoto, Kazumi ^a   Masuda, Daisaku ^a   Maeda, Norikazu ^a   Ohama, Tohru ^a   Ishigami, Masato ^b   Nishida, Makoto ^c   Hirano, Ken ichi ^a   Kihara, Shinji ^a   Hori, Masatsugu ^a   Shimomura, Iichiro ^a   Yamashita, Shizuya ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Division of Dermatology   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

ABCA1; Adiponectin; ApoA I; ApoB 100; HDL; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CELL STRAIN HEPG2; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIPOPROTEIN SYNTHESIS; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPONECTIN; ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; LIVER; MICE; MICE, KNOCKOUT;

MUS;

EID: 35348817457     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.038     Document Type: Article

References (19)

1. Miller N.E., La Ville A., and Crook D. Direct evidence that reverse cholesterol transport is mediated by high density lipoprotein in rabbit. Nature 314 (1985) 109-111
2. Yokoyama S. Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway. Curr. Opin. Lipidol. 16 (2005) 269-279
3. Wang N., Lan D., Cheng W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proc. Natl. Acad. Sci. USA 101 (2004) 9774-9779
4. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., and Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 (1999) 336-345
5. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsch-Ozcurumez M., Kaminski W.E., Hahmann H.W., Oette K., Rothe G., Aslanidis C., Lackner K.J., and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22 (1999) 347-351
6. Rust S., Walter M., Funke H., von Eckardstein A., Cullen P., Kroes H.Y., Hordijk R., Geisel J., Kastelein J., Molhuizen H.O., Schreiner M., Mischke A., Hahmann H.W., and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22 (1999) 352-355
7. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi T., Nagai M., Matsuzawa Y., and Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 68 (2004) 975-981
8. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., Arita Y., Okamoto Y., Shimomura I., Hiraoka H., Nakamura T., Funahashi T., Matsuzawa Y., and Osaka CAD Study Group. Coronary artery disease, Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 85-89
9. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., Malatino L.S., Bonanno G., Seminara G., Rapisarda F., Fatusso P., Buemi M., Nicocia G., Tanaka S., Ouchi N., Kihara S., Funahashi T., and Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13 (2002) 134-141
10. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., and Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
11. Ouchi N., Kihara S., Arita Y., Nishida M., Mastsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., and Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
12. Matsuura F., Oku H., Koseki M., Sandoval J.C., Yuasa-Kawase M., Tsubakio-Yamamoto K., Masuda D., Maeda N., Tsujii K., Ishigami M., Nishida M., Hirano K., Kihara S., Hori M., Shimomura I., and Yamashita S. Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem. Biophys. Res. Commun. 358 (2007) 1091-1095
13. Maeda N., Shimomura I., Kishida K., Nishizawa H., Mastuda M., Nagaretani H., Furuyama N., Kondo H., Takahasshi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., and Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
14. Usui S., Hara Y., Hosaki S., and Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res. 43 (2002) 805-814
15. Otabe S., Yuan X., Fukutani T., Wada N., Hashinaga T., Nakayama H., Hirota N., Kojima M., and Yamada K. Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am. J. Physiol. Endocrinol. Metab. 293 (2007) 210-218
16. Byrne C.D. Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype?. Atherosclerosis 145 (1999) 1-15
17. Neumeier M., Sigruener A., Eggenhofer E., Weigert J., Weiss T.S., Schaeffler A., Schlitt H.J., Aslanidis C., Piso P., Langmann T., Schmitz G., Scholmerich J., and Buechler C. High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes. Biochem. Biophys. Res. Commun. 352 (2007) 543-548
18. Gordon D.A., Jamil H., Sharp D., Mullaney D., Yao Z., Gregg R.E., and Wetterau J. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc. Natl. Acad. Sci. USA 91 (1994) 7628-7632
19. Lin M.C., Arbeeny C., Bergquist K., Kienzle B., Gordon D.A., and Wetterau J.R. Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides. J. Biol. Chem. 269 (1994) 29138-29145